Climb Bio, Inc. (CLYM) vs Phathom Pharmaceuticals, Inc. (PHAT)
- Climb Bio, Inc. CLYM 9.82 −9.99%
- Phathom Pharmaceuticals, Inc. PHAT 6.92 −7.73%
Climb Bio, Inc. and Phathom Pharmaceuticals, Inc. are both Biotechnology companies. Climb Bio, Inc. and Phathom Pharmaceuticals, Inc. are of similar size ($626.6M and $606.8M). Climb Bio, Inc. has the higher net margin (0.00% vs −41.3%) and the lower return on invested capital (−71.7% vs 0.00%). Across the 12 metrics below, Climb Bio, Inc. leads on 6 and Phathom Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | CLYM | PHAT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 82.92% | 65.16% |
| Operating margin | 0.00% | (16.96%) | 0.00% |
| Net margin | 0.00% | (41.34%) | 0.00% |
| Free cash flow margin | 0.00% | (15.40%) | 0.00% |
| Return on equity | (27.10%) | 26.42% | (56.36%) |
| Return on assets | (26.27%) | (34.32%) | (48.04%) |
| Return on invested capital | (71.73%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack